U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C20H18NO4.O4S.3H2O
Molecular Weight 822.831
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BERBERINE SULFATE TRIHYDRATE

SMILES

O.O.O.[O-]S([O-])(=O)=O.COC1=C(OC)C2=C(C=C1)C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=C2.COC6=C(OC)C7=C(C=C6)C=C8C9=CC%10=C(OCO%10)C=C9CC[N+]8=C7

InChI

InChIKey=FYBWCLKVKGHJKS-UHFFFAOYSA-L
InChI=1S/2C20H18NO4.H2O4S.3H2O/c2*1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2;1-5(2,3)4;;;/h2*3-4,7-10H,5-6,11H2,1-2H3;(H2,1,2,3,4);3*1H2/q2*+1;;;;/p-2

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C20H18NO4
Molecular Weight 336.3612
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula O4S
Molecular Weight 96.063
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://examine.com/supplements/berberine/ | https://www.ncbi.nlm.nih.gov/pubmed/19686830 | https://www.ncbi.nlm.nih.gov/pubmed/25610485

Berberine, an alkaloid isolated from Rhizoma Coptidis, is known to have a wide array of therapeutic effects including antimicrobial, antineoplastic, and hepatoprotective effects. It is found in several plants including European barberry, goldenseal, goldthread, Oregon grape, phellodendron, and tree tumeric. Berberine seems to slightly reduce blood sugar levels in people with diabetes. Berberine might lower blood pressure. Berberine is possibly safe for most adults for short-term use when taken by mouth or applied to the skin.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
1991 Jan-Feb
HIV-1 and HIV-2 reverse transcriptases: a comparative study of sensitivity to inhibition by selected natural products.
1992 May 29
[Determination of berberine in human serum by reversed-phase high performance liquid chromatography].
1997 Sep
Screening of compounds for antimicrosporidial activity in vitro.
1998
The effect of Kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of Tsu-kan-gan.
1998 Dec
Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2.
1998 Oct
Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans.
1999 May
Protective effect of berberine on cyclophosphamide-induced haemorrhagic cystitis in rats.
2001 May
Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium.
2002 Feb 19
Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration.
2002 Jan
Search of chemical scaffolds for novel antituberculosis agents.
2005 Apr
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.
2005 Nov
Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus.
2005 Winter
Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
2008 Feb 25
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
2008 Nov 5
Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study.
2010 Apr
[Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary].
2010 Feb
Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat.
2011 Apr
Characterization of protoberberine analogs employed as novel human P2X7 receptor antagonists.
2011 Apr 15
Berberine down-regulates the Th1/Th2 cytokine gene expression ratio in mouse primary splenocytes in the absence or presence of lipopolysaccharide in a preventive manner.
2011 Dec
Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver.
2011 Mar
Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms.
2011 Nov
The formation and stabilization of a novel G-quadruplex in the 5'-flanking region of the relaxin gene.
2012
Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii.
2012 Apr 15
Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine.
2012 Aug
Modulations of cytochrome P450 expression in diabetic mice by berberine.
2012 Mar 5
Mechanism study of goldenseal-associated DNA damage.
2013 Jul 31
Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth.
2013 Nov 1
The potential effect of berberine in mercury-induced hepatorenal toxicity in albino rats.
2014 Jul
Multiple mechanisms of cell death induced by chelidonine in MCF-7 breast cancer cell line.
2014 Nov 5
Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
2016 Jan 5
Patents

Sample Use Guides

500 mg of berberine 2-3 times daily for up to 3 months
Route of Administration: Oral
Berberine acted cytotoxically on both tumour cell lines. The melanoma B16 cells were much more sensitive to berberine treatment than the U937 cells. The value of IC(100) was below 100 ug/ml for the U937 cells and below 1 ug/ml for the B16 cells. As for both cell lines under the long-term influence the values of IC(50) were found to be less than 4 ug/ml.
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:07:37 GMT 2023
Edited
by admin
on Sat Dec 16 01:07:37 GMT 2023
Record UNII
T3MQ0UO932
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BERBERINE SULFATE TRIHYDRATE
MI  
Common Name English
BERBERINE SULFATE HYDRATE
JAN  
Common Name English
BERBERINE SESQUIHYDRATE SULFATE
Common Name English
BENZO(G)-1,3-BENZODIOXOLO(5,6-A)QUINOLIZINIUM, 5,6-DIHYDRO-9,10-DIMETHOXY-, SULFATE, HYDRATE (2:1:3)
Common Name English
BENZO(G)-1,3-BENZODIOXOLO(5,6-A)QUINOLIZINIUM, 5,6-DIHYDRO-9,10-DIMETHOXY-, SULFATE (2:1), TRIHYDRATE
Common Name English
BERBERINE SULFATE HYDRATE [JAN]
Common Name English
BERBERINE SULFATE TRIHYDRATE [MI]
Common Name English
Code System Code Type Description
FDA UNII
T3MQ0UO932
Created by admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
PRIMARY
PUBCHEM
71587234
Created by admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
PRIMARY
MERCK INDEX
m2426
Created by admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
PRIMARY Merck Index
CAS
69352-97-2
Created by admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY